Literature DB >> 32158574

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit.

Maria-Nikoletta Protopapa1, Maria Lagadinou1, Theodoros Papagiannis1, Charalambos A Gogos1, Elena E Solomou1.   

Abstract

Hepatocellular carcinoma (HCC) represents the most common type of primary cancer of the liver and is associated with poor prognosis. It is the most common cause of death in cirrhotic patients and in different studies was shown as the third most common cause of cancer-related deaths worldwide. Each year, approximately half a million people are diagnosed with HCC. In recent decades, the prognosis of patients with HCC has improved because more cases are diagnosed and treated at early stages; high-risk patients (i.e., with chronic HBV or HCV infection) are followed more often for the possibility of HCC, and novel treatment options such as locoregional therapy are used with better overall results. The extrahepatic metastases represent a poor prognostic factor. The most common sites of metastasis in advanced hepatocellular carcinoma are the lung (44%), portal vein (35%), and portal lymph nodes (27%). Also, intra-abdominal lymph nodes and bones are common sites. Orbital metastases rarely occur, representing the 3-7% of orbital masses. These metastases are usually found in advanced tumor stages. The mechanism of metastasis to the orbit is difficult to determine. A hematogenous route, as for other primary neoplasms of the abdomen, may be suspected. Tumor cells may circulate through the vena cava, beyond the pulmonary filter to the heart, and finally be distributed to the orbital region through the arterial systemic circulation. We describe herein a case of an adult male with liver cirrhosis due to alcohol abuse who presented with concomitant diagnosis of HCC and orbit metastasis.
Copyright © 2020 Maria-Nikoletta Protopapa et al.

Entities:  

Year:  2020        PMID: 32158574      PMCID: PMC7061109          DOI: 10.1155/2020/7526042

Source DB:  PubMed          Journal:  Case Rep Oncol Med


  9 in total

1.  Orbital metastases: diagnosis and course.

Authors:  D H Char; T Miller; S Kroll
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  Orbital metastasis from hepatocellular carcinoma.

Authors:  Luis Téllez-Villajos; Maite Maroto-Castellanos; José Luis Lledó-Navarro; Sergio López-Durán; Víctor Moreira-Vicente; Agustín Albillos-Martínez
Journal:  Rev Esp Enferm Dig       Date:  2015-04       Impact factor: 2.086

3.  Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective.

Authors:  Ali Abbas; Sabeen Medvedev; Nathan Shores; Lydia Bazzano; Ahmed Dehal; Jay Hutchings; Luis Balart
Journal:  Dig Dis Sci       Date:  2014-06-06       Impact factor: 3.199

4.  A case of hepatocellular carcinoma in an elder man with metastasis to the nasopharynx.

Authors:  Shuangshuang Guo; Ying Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 5.  Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma.

Authors:  Terence C Chua; David L Morris
Journal:  Surg Oncol       Date:  2011-03-11       Impact factor: 3.279

6.  Screening for extrahepatic metastases by additional staging modalities is required for hepatocellular carcinoma patients beyond modified UICC stage T1.

Authors:  Jieun Yi; Geum-Youn Gwak; Dong Hyun Sinn; Yu Jin Kim; Ha Na Kim; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  Hepatogastroenterology       Date:  2013 Mar-Apr

7.  An unusual initial presentation of hepatocellular carcinoma as a sellar mass.

Authors:  Nihar Shah; Yana Cavanagh; Hamid Shaaban; Beth Stein; Sohail N Shaikh; Dharmesh H Kaswala; Walid Baddoura
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

8.  Hepatocellular Carcinoma Metastasis to the Orbit in a Coinfected HIV+ HBV+ Patient Previously Treated with Orthotopic Liver Transplantation: A Case Report.

Authors:  S Guerriero; G Infante; E Giancipoli; S Cocchi; M G Fiore; D Piscitelli; N Cardascia
Journal:  Case Rep Ophthalmol Med       Date:  2011-12-20

9.  Retrobulbar metastasis and intracranial invasion from postoperative hepatocellular carcinoma: A case report and review of the literature.

Authors:  Chun-Yong Chen; Jian-Hong Zhong; Jing-Li Liu
Journal:  Oncol Lett       Date:  2014-11-24       Impact factor: 2.967

  9 in total
  2 in total

1.  LncRNA-URHC Functions as ceRNA to Regulate DNAJB9 Expression by Competitively Binding to miR-5007-3p in Hepatocellular Carcinoma.

Authors:  Kunwei Niu; Shibin Qu; Xuan Zhang; Jimin Dai; Jianlin Wang; Ye Nie; Hong Zhang; Kaishan Tao; Wenjie Song
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-07       Impact factor: 2.629

2.  New approach for hepatocellular carcinoma treatment.

Authors:  Daniela Tabacelia; Cezar Stroescu; Radu Dumitru; Raluca Roxana Grigorescu; Alexandru Martiniuc; Ioana Alexandra Husar-Sburlan; Narcis Copca
Journal:  J Med Life       Date:  2022-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.